>Mercado europeo del síndrome de Down, por tipo de enfermedad (trisomía 21, síndrome de Down por translocación , síndrome de Down en mosaico), tratamiento ( diagnóstico , terapia), usuario final (hospital, clínicas, centros de atención domiciliaria, centros de terapia, otros), canal de distribución (licitación directa, ventas minoristas, otros), país (Alemania, Reino Unido, Francia, Italia, España, Rusia, Polonia, Suiza, Países Bajos, Hungría, Austria, Noruega, Irlanda, Turquía, Lituania y resto de Europa) Tendencias de la industria y pronóstico hasta 2028
Análisis y perspectivas del mercado: mercado del síndrome de Down en Europa
Se espera que el mercado del síndrome de Down gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 13,78% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 725,12 millones para 2028. La creciente conciencia sobre la enfermedad y la creciente prevalencia del síndrome de Down son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.
Los avances tecnológicos y el creciente apoyo gubernamental son los principales impulsores que han impulsado la demanda del mercado del síndrome de Down en el período de pronóstico.
El síndrome de Down es una enfermedad genética que se produce debido a una división celular anormal. Esta división celular anormal provoca la obtención de una copia adicional, total o parcial, del cromosoma 21. La presencia de material genético adicional provoca cambios físicos y de desarrollo en las personas que dan lugar al síndrome de Down. La anomalía genética más común asociada con el síndrome de Down incluye discapacidades mentales, principalmente discapacidades de aprendizaje en los niños.
La concienciación ha permitido a estas personas optar por nuevos enfoques de diagnóstico junto con terapias avanzadas para establecer un estilo de vida saludable. Esto significa que la creciente conciencia sobre la enfermedad está actuando como motor para el crecimiento del mercado del síndrome de Down . Las complicaciones significan que la falta de disponibilidad de un tratamiento específico actúa como un freno para el crecimiento del mercado del síndrome de Down . Los actores del mercado que operan en el mercado del síndrome de Down están adoptando varias iniciativas estratégicas que se espera que impulsen su negocio en varias dimensiones, actuando como una oportunidad para el crecimiento del mercado del síndrome de Down . El largo tiempo de aprobación asociado con el lanzamiento del producto actúa como un desafío para el crecimiento del mercado del síndrome de Down .
El informe de mercado del síndrome de Down proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado , aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado del síndrome de Down , comuníquese con Data Bridge Market Research para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado del síndrome de Down
El mercado del síndrome de Down está segmentado en función del tipo de enfermedad, el tratamiento , el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- Según el tipo de enfermedad, el mercado del síndrome de Down se segmenta en trisomía 21, síndrome de Down por translocación y síndrome de Down en mosaico. En 2021, el segmento de la trisomía 21 domina el mercado, ya que más del 95 por ciento de los casos de síndrome de Down son trisomía 21.
- En función del tratamiento, el mercado del síndrome de Down se segmenta en diagnóstico y terapia. En 2021, el segmento de diagnóstico domina el mercado, ya que la mayoría de los padres se realizan pruebas prenatales para comprender el estado del feto.
- En función del usuario final, el mercado del síndrome de Down se segmenta en hospitales , clínicas, centros de atención domiciliaria, centros de terapia y otros. En 2021, el segmento hospitalario domina el mercado porque son los principales establecimientos para las pruebas prenatales.
- En función del canal de distribución, el mercado del síndrome de Down se segmenta en licitación directa, ventas minoristas y otros. En 2021, el segmento de licitación directa domina el mercado, ya que es el principal modo de compra de productos de diagnóstico por parte de hospitales y clínicas.
Análisis del mercado del síndrome de Down a nivel de país
Se analiza el mercado del síndrome de Down y se proporciona información sobre el tamaño del mercado por país, tipo de enfermedad, tratamiento, usuario final y canal de distribución como se menciona anteriormente.
Los países cubiertos en el informe del mercado del síndrome de Down son Alemania, Reino Unido, Francia, Italia, España, Rusia, Polonia, Suiza, Países Bajos, Hungría, Austria, Noruega, Irlanda, Turquía, Lituania y el resto de Europa.
Se espera que Europa crezca con la CAGR más alta en el período de pronóstico, ya que el diagnóstico del síndrome de Down es una prueba de rutina en la mayoría de los países. Se espera que Alemania domine el mercado en Europa. Alemania es uno de los países líderes que tiene un enorme potencial de mercado en Europa y una mayor demanda de diagnóstico del síndrome de Down.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Government Support and Increasing Research and Development are Boosting the Market Growth of Down syndrome
Down syndrome market also provides you with detailed market analysis for every country growth in Down syndrome industry with Down syndrome drugs sales, impact of advancement in the Down syndrome technology and changes in regulatory scenarios with their support for the Down syndrome market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Down syndrome Market Share Analysis
Down syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Down syndrome market.
The major companies which are dealing in the Down syndrome are F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Abbott, Natera, Inc, AtilaBiosystems, Physio.co.uk, Novus Biologicals (a subsidiary of Bio-Techne), Down Syndrome Cork, a branch of Down Syndrome Ireland, Demeditec Diagnostics GmbH, Symbol, ASDclinic.co.uk among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Down syndrome market.
For instance,
- In April 2017, Illumina, Inc. launched VeriSeq NIPT solution in Europe. The product launched is a CE-IVD marked next-generation sequencing technology-based approach used for screening of chromosomal abnormalities and proved efficacious for providing accurate information about chromosomal status within 10 weeks of gestation. This product launch boosted the company’s product portfolio and allowed it to penetrate its root in worldwide Down syndrome market.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias del actor del mercado están mejorando el mercado de la empresa en el mercado del síndrome de Down, lo que también proporciona el beneficio para que la organización mejore su oferta para el síndrome de Down.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE Down syndrome MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- treatment of Down syndrome LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET END USER COVERAGE GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Europe DOWN SYNDROME MARKET: Pipeline analysis
- PIPELINE PRODUCTS IMPACT ANALYSIS
- NNI-351
- ASPARAGINASE
- ANVS-401
- QUILLIVANT XR
- TOFACITINIB
- MEMANTINE HYDROCHLORIDE
- NICOTINE
- AEF0217
- ACI-24
- Europe DOwn syndrome Market: Laws and regulations
- Market Overview
- Drivers
- increasing prevalence OF DOWN syndrome
- rising demand of effective therapies
- rising awareness about the diseasE
- technological ADVANCEMENTS
- increasing government support
- RESTRAINTS
- UNAVAILABILITY OF any specific treatment
- Side Effects Associated With Down Syndrome Treatment Therapies
- high cost of diagnosis
- opportunities
- STRATEGIC INITIATIVES BY MARKET PLAYERS
- increasing research and development
- presence of pipeline therapies
- presence of reimbursement
- challenGes
- Lack of Skilled Proffessionals
- Long Process for Product Launch
- Transfer of COVID-19 Infections by Diagnostic Methods
- Impact of COVID-19 on Europe Down Syndrome Market
- Price Impact
- Impact on Supply Chain
- Impact on Demand
- Strategic Decisions for Manufacturers
- Conclusion
- Europe Down syndrome MARKET, BY disease Type
- overview
- trisomy 21
- translocation Down syndrome
- mosaic Down syndrome
- Europe Down syndrome MARKET, BY treatment
- overview
- diagnosis
- Screening Tests
- First Trimester
- Blood Test
- Nuchal Translucency Testing
- Integrated Screening Test
- First Trimester
- Second Trimester
- The Triple Screen or Quadraple Screen Test
- Ultrasound
- Cell Free DNA
- Diagnostic Tests
- Chronic Villus Sampling
- Amniocentesis
- Precutaneous Umbical Cord Sampling
- therapy
- Early Intervention Therapy
- Speech-Language Therapy
- Physical Therapy
- Occupational Therapy
- Others
- Assistive Technology
- Hearing Aids
- Glasses
- Others
- Surgery
- Atrioventricular Septal Defect (AVSD)
- Duodenal Atresia
- Others
- Others
- Europe Down syndrome MARKET, BY end user
- overview
- hospital
- clinics
- homecare setting
- others
- Europe Down syndrome MARKET, BY distribution channel
- overview
- direct tender
- retail sales
- others
- EUROPE Down syndrome MARKET, by Geography
- europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Poland
- Switzerland
- Netherlands
- Hungary
- Austria
- Norway
- Ireland
- Turkey
- Lithuania
- Rest of Europe
- Europe Down syndrome market: COMPANY landscape
- company share analysis: Europe
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- Company ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- PerkinElmer Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Illumina, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Thermo Fisher Scientific Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Myriad Genetics, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Abnova Corporation
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ASDclinic.co.uk
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- AtilaBiosystems
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Boston Children's Hospital
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Boys Town National Research Hospital
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Children's Hospital Colorado
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Demeditec Diagnostics GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Down Syndrome Cork
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Mayo Clinic Health System
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- Natera, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Next Biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Novus Biologicals (A Subsidiary of Bio-Techne)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Kid Sense Child Development Corporation Pty Ltd
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- Physio.co.uk.
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- Symbol
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Lista de Tablas
TABLE 1 Europe Down syndrome market: Pipeline Analysis
TABLE 2 REGULATION imposed by several regulatory agencies in different regions
TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)
TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)
TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)
TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)
TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)
TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)
TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)
TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)
TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)
TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)
Lista de figuras
FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION
FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION
FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS
FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID
FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Europe Down syndrome market: SEGMENTATION
FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market
FIGURE 15 Europe Down syndrome market: BY disease type, 2020
FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)
FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)
FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE
FIGURE 1 Europe Down syndrome market: BY treatment, 2020
FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).
FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)
FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE
FIGURE 5 Europe Down syndrome market: BY end user, 2020
FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)
FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)
FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE
FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020
FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)
FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE
FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)
FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)
FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)
FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)
FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)
FIGURE 18 Europe Down syndrome market: company share 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
